Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents
- Supplementary File 1:
PDF-Document (PDF, 3115 KiB)
Nascimento da Cruz, A.C.; Brondani, D.J.; I´talo de Santana, T.; Oliveira da Silva, L.; da Oliveira Borba, E.F.; de Faria, A.R.; Ferreira Cavalcanti de Albuquerque, J.; Piessard, S.; Matos Ximenes, R.; Baratte, B.; Bach, S.; Ruchaud, S.; Bezerra Mendonça Junior, F.J.; Bazin, M.-A.; Montenegro Rabello, M.; Hernandes, M.Z.; Marchand, P.; Gonçalves da Silva, T. Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents. Pharmaceuticals 2019, 12, 169. https://doi.org/10.3390/ph12040169
Nascimento da Cruz AC, Brondani DJ, I´talo de Santana T, Oliveira da Silva L, da Oliveira Borba EF, de Faria AR, Ferreira Cavalcanti de Albuquerque J, Piessard S, Matos Ximenes R, Baratte B, Bach S, Ruchaud S, Bezerra Mendonça Junior FJ, Bazin M-A, Montenegro Rabello M, Hernandes MZ, Marchand P, Gonçalves da Silva T. Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents. Pharmaceuticals. 2019; 12(4):169. https://doi.org/10.3390/ph12040169
Chicago/Turabian StyleNascimento da Cruz, Anne Cecília, Dalci José Brondani, Temístocles I´talo de Santana, Lucas Oliveira da Silva, Elizabeth Fernanda da Oliveira Borba, Antônio Rodolfo de Faria, Julianna Ferreira Cavalcanti de Albuquerque, Sylvie Piessard, Rafael Matos Ximenes, Blandine Baratte, Stéphane Bach, Sandrine Ruchaud, Francisco Jaime Bezerra Mendonça Junior, Marc-Antoine Bazin, Marcelo Montenegro Rabello, Marcelo Zaldini Hernandes, Pascal Marchand, and Teresinha Gonçalves da Silva. 2019. "Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents" Pharmaceuticals 12, no. 4: 169. https://doi.org/10.3390/ph12040169